No definition available.
Carcinoma in situ of other and unspecified sites
DOID EFO Endpoint Browser PheWeb
CD2_INSITU_OTHER_NOS
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
178 |
4. Check minimum number of eventsNone |
178 |
5. Include endpoints |
1640 |
6. Filter based on genotype QC (FinnGen only) |
1491 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ locis aliis sive non specificatis
Carcinoma in situ of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1491 | 318 | 1173 |
| Unadjusted period prevalence (%) | 0.45 | 0.11 | 0.54 |
| Median age at first event (years) | 72.63 | 68.82 | 73.66 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1538
- Matched controls
- 15380
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
36.1
307.7
239
78
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
5659.7
307.7
999
5
ZX136
NOMESCO Finland
Intravesicalis
40.6
307.7
205
58
UKC02
NOMESCO Finland
Cystoscopy
42.2
307.7
1370
2489
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
134.0
307.7
703
96
KCD02
NOMESCO Finland
Transurethral resection of bladder
119.3
307.7
983
225
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
65.5
307.7
414
86
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
130.2
307.7
947
187
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
120.5
307.7
887
172
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
92.4
307.7
438
66
R31
ICD-10 Finland
Unspecified haematuria
10.9
307.7
861
1601
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
73.1
307.7
610
137
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
82.7
229.5
122
16
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
21.7
209.8
160
82
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
927.8
172.5
166
*
KCW96
NOMESCO Finland
Other operations on bladder
32.7
160.3
104
34
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
42.9
148.0
89
22
C67
ICD-10 Finland
Malignant neoplasm of bladder
46.0
147.2
87
20
WX320
NOMESCO Finland
Spinalanesthesy
3.7
136.4
715
2930
KH1AD
NOMESCO Finland
CT of urinary organs
7.5
129.6
200
301
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
665.8
126.3
123
*
U06
ICPC
Haematuria
7.1
124.3
202
321
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
112.9
107
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
25.2
99.1
70
29
KH1DD
NOMESCO Finland
CT urography of urinary organs
31.8
98.1
64
21
UKB02
NOMESCO Finland
Retrograde ureteroscopy
12.3
95.4
97
84
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
13.9
93.6
88
67
XKD00
NOMESCO Finland
Uroflowmetry
3.0
92.7
647
2997
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.1
89.9
287
815
TKC20
NOMESCO Finland
Catheterisation of bladder
4.0
88.3
296
870
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
43.9
85.3
51
12
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.9
83.4
552
2457
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.8
77.3
126
199
WX402
NOMESCO Finland
General anaesthesia
2.9
75.7
487
2118
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
8.6
72.0
94
115
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
9.9
71.8
84
89
KCB00
NOMESCO Finland
Biopsy of bladder
22.4
70.4
52
24
WX224
NOMESCO Finland
Blockade of obturius nerve
148.8
67.5
71
5
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.9
64.8
371
1499
J01MA02
ATC
ciprofloxacin; systemic
2.3
54.8
819
5105
U76
ICPC
Malignant neoplasm of bladder
20.0
53.0
41
21
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.6
49.5
82
131
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
48.2
528
2856
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
47.1
45
*
N30.0
ICD-10 Finland
Acute cystitis
2.7
46.9
294
1228
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
16.2
44.4
38
24
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
39.2
331
1582
KED22
NOMESCO Finland
Transurethral resection of prostate
2.6
36.8
247
1059
G04BD12
ATC
mirabegron; oral
2.4
36.7
312
1491
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
6.0
35.6
64
111
KDV10
NOMESCO Finland
Internal urethrotomy
5.2
34.6
72
143
ZXC20
NOMESCO Finland
Use of chemical agents
4.5
33.8
85
198
U07
ICPC
Urine symptom/complaint other
2.7
33.2
205
842
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
33.1
294
1427
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.5
32.9
83
194
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
38.3
32.6
41
11
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
31.4
30
*
4CX01, ,
NOMESCO Finland
112.4
30.8
33
*
ZXE00
NOMESCO Finland
One hour or less
1.9
30.1
642
4259
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
7.9
29.9
41
53
JN4AD
NOMESCO Finland
Body CT examination
2.2
29.6
295
1497
D09.9
ICD-10 Finland
Carcinoma in situ, unspecified
297.4
28.9
29
*
R33
ICD-10 Finland
Retention of urine
2.2
27.3
268
1348
G04CA02
ATC
tamsulosin; oral
1.8
27.3
732
5165
ZXC15
NOMESCO Finland
Use of photodynamic technique
4.5
26.6
65
148
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
9.3
26.6
32
35
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
26.2
320
1747
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
95.1
25.7
28
*
J01EA01
ATC
trimethoprim; systemic
2.0
25.4
363
2092
C66
ICD-10 Finland
Malignant neoplasm of ureter
23.8
24.8
35
15
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.6
24.7
83
239
A98
ICPC
Health maint/preventive medicine
3.0
24.2
1450
12995
N30.9
ICD-10 Finland
Cystitis, unspecified
2.8
23.5
120
444
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
4.9
22.6
50
105
KBV10
NOMESCO Finland
Removal of stent from ureter
6.4
22.3
37
59
KCD30
NOMESCO Finland
Destruction of tumour of bladder
24.3
22.2
31
13
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
50.8
21.2
25
5
J01DB01
ATC
cefalexin; oral
1.9
21.0
1236
10541
WZC30
NOMESCO Finland
Teaching
1.9
20.2
313
1839
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.1
20.1
27
34
N02BE01
ATC
paracetamol; systemic, rectal
2.2
19.9
1374
12212
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
24.9
19.6
27
11
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
4.5
19.3
47
107
KCC10
NOMESCO Finland
Cystoprostatectomy
5.8
18.1
33
58
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
3.6
17.9
59
168
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
17.5
867
6878
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
6.7
17.1
27
41
UKD02
NOMESCO Finland
Urethroscopy
6.3
16.8
28
45
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
16.7
16
*
J01MA12
ATC
levofloxacin; systemic
1.7
16.3
355
2291
U29
ICPC
Urinary symptom/complaint other
2.8
15.9
80
294
D09.1
ICD-10 Finland
Carcinoma in situ: Other and unspecified urinary organs
+∞
15.6
15
*
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
15.6
15
*
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
15.4
553
4035
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
6.5
15.4
25
39
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
15.3
994
8272
B02AA02
ATC
tranexamic acid; systemic
2.1
15.0
154
780
SPAT1262
SPAT
Handing over of treatment supplies
1.7
14.5
335
2189
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
151.4
14.5
15
*
WX702
NOMESCO Finland
Supraglottic ventilation device
2.4
14.2
96
409
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
14.1
118
551
G04CA01
ATC
alfuzosin; oral
1.6
14.0
352
2348
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
13.6
13
*
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
16.9
13.0
20
12
R39.1
ICD-10 Finland
Other difficulties with micturition
2.5
12.9
80
327
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
22.7
12.9
18
8
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
12.7
558
4214
D09.7
ICD-10 Finland
Carcinoma in situ of other specified sites
+∞
12.5
12
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
24.5
12.5
17
7
TKD00
NOMESCO Finland
Dilatation of urethra
4.6
12.4
29
64
Z3231
NOMESCO Finland
Registered nurse
1.5
12.4
432
3103
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.7
12.2
258
1639
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
12.1
183
1057
KBH20
NOMESCO Finland
Replantation of ureter
21.5
12.0
17
8
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
3.9
11.9
34
88
N21.0
ICD-10 Finland
Calculus in bladder
3.6
11.8
38
107
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
11.5
915
7709
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
9.3
11.5
23
25
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
11.5
11
*
S18
ICPC
Laceration/cut
1.5
11.4
764
6227
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
11.4
476
3542
KH1AE, ,
SPAT
3.5
11.3
38
110
SPAT1263
SPAT
Sampling
1.5
11.3
607
4744
8130/1-C67.9
ICD-O-3
Papillary urothelial neoplasm of low malignant potential of bladder, NOS
25.2
11.1
15
6
U01
ICPC
Dysuria/painful urination
2.2
11.1
97
462
A02BC02
ATC
pantoprazole; systemic
1.5
11.0
1032
8934
U13
ICPC
Bladder symptom/complaint other
2.7
10.6
58
224
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
10.5
703
5698
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.2
10.5
40
126
KBV00
NOMESCO Finland
Insertion of stent into ureter
5.5
10.4
20
37
G04BD08
ATC
solifenacin; oral
1.9
10.4
127
684
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
10.2
629
5016
SPAT1167
SPAT
Insertion of urinary catheter
2.2
10.2
83
384
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
10.2
236
1532
U05
ICPC
Urination problems other
2.0
10.0
118
628
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
9.8
215
1375
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
8.8
9.8
20
23
K02.1
ICD-10 Finland
Caries of dentine
1.4
9.8
727
5980
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
9.6
588
4671
TKC22
NOMESCO Finland
Catheterisation instruction
2.4
9.6
67
291
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.5
9.5
304
2126
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.6
9.5
52
201
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.4
9.5
66
286
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
9.3
367
2679
U08
ICPC
Urinary retention
2.3
9.3
66
288
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
9.2
140
809
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.0
9.1
95
484
KDE20
NOMESCO Finland
Removal of foreign body from urethra
3.5
8.9
30
87
WX720
NOMESCO Finland
Own respiration
2.1
8.9
85
419
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
4.4
8.9
22
51
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
8.9
444
3391
KA3EB
NOMESCO Finland
Antegrade pyelography
4.7
8.8
20
43
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
8.8
330
2382
OAB50, ,
SPAT
1.8
8.8
146
866
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
8.7
681
5613
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.2
8.7
34
109
U02
ICPC
Urinary frequency/urgency
1.6
8.6
192
1232
-1, ,
NOMESCO Finland
1.5
8.5
376
2801
KGH10
NOMESCO Finland
Operation for phimosis
2.2
8.5
67
306
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
8.5
363
2689
J01CA08
ATC
pivmecillinam; oral
1.5
8.4
307
2202
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
8.4
540
4298
G04CB01
ATC
finasteride; oral
1.5
8.4
318
2298
T90
ICPC
Diabetes non-insulin dependent
1.4
8.2
437
3366
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
8.1
425
3263
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
8.1
448
3472
XQ848
NOMESCO Finland
Dermatological photography
2.3
8.1
59
261
U70
ICPC
Pyelonephritis/pyelitis
3.2
8.1
31
98
JN4CD
NOMESCO Finland
Very extensive body CT
2.1
7.9
76
376
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.9
630
5182
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
7.8
787
6706
J01CA04
ATC
amoxicillin; systemic
1.4
7.7
1105
9944
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.8
7.7
105
587
Z01.2
ICD-10 Finland
Dental examination
1.4
7.7
532
4274
B01AB05
ATC
enoxaparin; parenteral
1.4
7.6
483
3824
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
3.1
7.6
30
97
KBD00
NOMESCO Finland
Partial excision of ureter
25.1
7.6
10
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
7.5
538
4340
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.1
7.5
69
336
4078, ,
NOMESCO Finland
80.5
7.4
8
*
H13
ICPC
Plugged feeling ear
1.4
7.4
346
2597
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
7.3
1045
9350
8130/2-C67.1
ICD-O-3
Papillary urothelial carcinoma, non-invasive of dome of bladder
+∞
7.3
7
*
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.8
7.2
108
622
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.4
7.1
304
2243
KED33
NOMESCO Finland
Transurethral incision of prostate
2.5
7.1
43
175
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
7.1
202
1372
D06
ICPC
Abdominal pain localized other
1.8
7.1
105
602
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
12.1
7.1
12
10
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.6
7.1
163
1055
RD211, ,
NOMESCO Finland
2.1
7.1
67
331
P17
ICPC
Tobacco abuse
3.6
7.0
22
61
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
7.0
159
1025
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
6.9
126
767
SFA20
NOMESCO Finland
Two-surface restoration
1.3
6.9
694
5873
WVA20
NOMESCO Finland
Medicine administration
2.2
6.9
53
241
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
3.4
6.8
24
72
B01AB10
ATC
tinzaparin; parenteral
1.6
6.8
165
1082
N02AX02
ATC
tramadol; systemic, rectal
1.3
6.6
637
5354
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.5
6.5
247
1783
N30
ICD-10 Finland
Cystitis
1.9
6.5
76
406
KDD32
NOMESCO Finland
Urethroscopic destruction of tumour of urethra
70.1
6.4
7
*
A03
ICPC
Fever
1.5
6.4
180
1219
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.4
6.4
262
1916
N02
ICD-10 Finland
Recurrent and persistent haematuria
14.4
6.4
10
7
SPAT1325
SPAT
Vaccination
1.3
6.4
527
4322
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
6.3
258
1886
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.3
427
3399
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
6.3
376
2934
KAC20
NOMESCO Finland
Nephroureterectomy
11.1
6.3
11
10
KC1GD
NOMESCO Finland
CT cystography of bladder
11.1
6.3
11
10
KBB00
NOMESCO Finland
Biopsy of ureter
18.1
6.3
9
5
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
26.8
6.2
8
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
6.2
144
933
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.2
446
3584
WX290
NOMESCO Finland
Other blockage of nerve
1.3
6.2
502
4106
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.9
6.1
71
377
ZXC50
NOMESCO Finland
Cryotherapy
2.0
6.0
66
344
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
6.0
165
1112
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
871
3722
4.09
162.64
6.1
2.8
3.50
3.68
e6/l
0.25
830
3418
1052
5247
4.18
153.91
10.8
3.7
345.93
97.00
e6/l
1.58
919
4156
945
4505
3.85
144.92
10.2
3.6
0.19
0.48
e6/l
9.34
821
3438
1069
5669
3.90
136.22
11.9
4.3
184.87
108.63
e6/l
1.14
944
4251
1397
9198
6.66
126.07
13.7
5.0
1490.26
1586.75
e6/l
0.02
31
159
1146
7133
3.38
97.35
6.7
4.1
0.00
0.00
estimate
-0.00
336
1597
1155
7237
3.39
96.69
6.7
4.1
0.02
3.89
estimate
1.33
345
1627
410
1444
3.51
93.82
5.6
2.6
0.22
0.47
e6/l
2.39
405
1390
1150
7277
3.30
92.73
6.8
4.1
0.04
0.21
estimate
0.40
316
1492
1061
6601
2.96
84.42
3.6
3.1
—
—
estimate
—
0
0
602
2864
2.81
79.58
10.3
3.3
1.01
0.95
e6/l
0.18
448
1628
569
2651
2.82
78.02
11.0
3.4
1.02
1.26
e6/l
0.67
418
1409
640
3684
2.26
50.84
6.1
3.7
0.08
0.04
estimate
0.35
239
1234
1186
8818
2.51
50.25
6.0
5.7
6.86
6.93
mmol/l
0.75
1161
8469
820
5323
2.16
47.03
7.0
4.2
0.03
0.02
estimate
0.14
273
1338
689
4183
2.17
46.95
6.6
4.2
0.00
0.00
estimate
0.78
301
1393
605
3518
2.19
45.71
5.1
3.1
0.25
0.04
0.99
20
113
201
729
3.02
41.43
2.8
2.2
0.05
1.30
estimate
0.48
42
196
1058
7802
2.14
40.78
21.1
20.3
1.33
1.37
inr
1.58
903
6620
1444
12434
3.64
36.05
26.0
20.7
31.31
29.43
mg/l
1.18
1298
10644
1473
13056
4.03
30.63
32.6
25.4
139.57
139.62
mmol/l
0.38
1458
12813
1473
13068
4.01
30.33
33.0
25.7
4.04
4.02
mmol/l
1.19
1458
12809
1395
12035
2.71
29.76
28.9
20.5
70.46
73.24
ml/min/173m2
5.94
1350
11298
1477
13205
3.99
28.37
37.3
27.8
93.12
88.85
umol/l
3.21
1466
13041
1479
13268
3.99
27.53
40.1
31.0
91.94
92.03
fl
0.29
1467
13087
1479
13269
3.99
27.51
40.2
31.1
235.64
232.68
e9/l
1.04
1451
12958
1479
13269
3.99
27.51
40.8
31.7
39.81
40.02
%
0.76
1467
13080
1479
13269
3.99
27.51
40.2
31.0
4.41
4.43
e12/l
0.61
1448
12901
1479
13270
3.99
27.48
40.3
31.1
7.25
7.01
e9/l
3.70
1449
12901
1479
13271
3.98
27.46
40.6
31.3
132.34
134.19
g/l
4.16
1467
13096
1060
8462
1.81
24.84
6.5
6.2
3.05
3.81
ug/l
0.52
970
7576
1258
10612
2.02
24.73
9.9
9.0
80.41
82.42
u/l
0.79
1206
10074
1453
13027
3.09
24.45
15.0
13.6
25.65
25.91
u/l
0.25
1415
12573
982
7772
1.73
22.54
7.2
7.1
11.10
12.85
umol/l
7.32
950
7447
1177
9831
1.84
22.21
4.8
4.5
15.28
13.99
mm/h
1.65
1075
9080
984
7830
1.71
21.76
9.8
9.7
4.66
4.41
e9/l
2.28
840
6753
889
6904
1.68
21.35
6.0
5.5
34.32
34.62
g/l
0.87
839
6452
540
3677
1.72
21.32
3.0
2.7
—
—
—
0
0
1372
12167
2.18
20.31
5.8
5.6
4.20
4.28
mmol/l
2.37
1251
11133
169
793
2.27
20.10
7.3
3.6
1.02
1.02
ratio
0.06
164
734
1391
12440
2.24
19.52
6.7
6.5
2.38
2.45
mmol/l
2.11
1263
11330
1361
12078
2.10
19.38
5.7
5.5
1.32
1.37
mmol/l
5.36
1227
10954
1375
12261
2.15
19.13
6.4
5.9
6.26
6.15
mmol/l
2.27
1226
11030
1359
12082
2.07
18.81
8.6
7.6
41.43
40.66
mmol/mol
2.48
1252
11135
966
7804
1.64
18.66
8.1
8.1
1.21
1.20
mmol/l
0.74
837
6700
1163
9895
1.72
18.01
33.5
25.5
13.99
13.92
%
0.93
1154
9764
630
4620
1.62
17.86
3.0
2.8
59.27
77.30
u/l
0.50
591
4273
761
5953
1.55
15.64
17.3
13.1
0.00
0.00
e9/l
0.14
628
4861
754
5898
1.55
15.42
3.5
3.2
157.32
176.57
ug/l
1.23
681
5389
1302
11606
1.79
15.09
4.9
4.7
1.33
1.27
mmol/l
2.47
1151
10424
770
6075
1.54
14.98
2.5
2.3
—
—
—
0
0
582
4320
1.56
14.94
2.6
2.4
3.03
2.94
mg/l
0.36
492
3702
1283
11410
1.75
14.71
5.4
4.9
2.00
2.06
mu/l
0.82
1131
10274
512
3710
1.57
14.52
5.0
4.4
84.18
81.43
%
1.67
505
3637
273
1710
1.73
13.76
4.9
3.9
—
—
—
0
0
840
6831
1.51
13.65
5.2
5.1
21.30
21.97
%
0.67
481
3699
626
4848
1.49
12.57
1.8
1.8
19.14
19.54
nmol/l
0.25
519
4084
133
693
2.01
11.98
3.3
3.2
24.11
24.59
mmol/l
0.63
133
683
385
2728
1.55
11.61
3.0
2.8
2.30
2.21
g/l
2.11
351
2530
1063
9248
1.48
11.16
4.3
3.8
15.11
15.05
pmol/l
0.29
931
8230
363
2560
1.55
11.12
3.0
2.9
18.72
22.56
%
7.53
336
2395
628
4955
1.45
11.05
3.5
3.6
0.75
0.82
ug/l
1.00
475
3567
205
1257
1.73
11.02
4.4
3.9
5.09
5.09
kpa
0.04
200
1200
421
3075
1.51
10.93
2.0
2.0
—
—
—
0
0
930
7917
1.44
10.70
3.4
3.5
55.49
59.93
u/l
0.65
859
7299
398
2896
1.50
10.45
3.0
2.8
10.78
12.36
umol/l
4.92
370
2706
671
5444
1.41
9.75
3.7
3.6
7.40
7.73
mmol/l
1.44
539
4532
680
5531
1.41
9.73
4.7
4.4
10.49
9.41
mg/mmol
0.22
472
3680
824
6947
1.40
9.47
2.4
2.3
92.25
92.71
pmol/l
0.10
468
3890
368
2684
1.49
9.42
2.0
2.1
29.97
30.07
s
0.15
362
2609
831
7022
1.40
9.39
7.3
7.2
1.21
1.20
mmol/l
0.92
762
6469
678
5553
1.40
9.13
3.7
3.4
2081.41
1827.52
ng/l
0.44
611
4917
730
6092
1.38
8.60
5.3
4.5
249.01
83.64
ng/l
0.37
630
4938
186
1202
1.62
8.13
1.8
1.7
—
—
—
0
0
259
1826
1.50
7.69
3.8
4.3
19.94
29.22
ug/l
0.36
218
1545
167
1072
1.63
7.49
4.0
3.7
1.29
1.88
mmol/l
1.39
127
776
607
5026
1.34
7.07
4.0
3.6
2.34
2.34
mmol/l
0.04
549
4513
591
4876
1.34
7.05
2.5
2.3
250.87
251.43
u/l
0.00
555
4610
190
1279
1.55
6.97
4.4
4.4
1.22
1.22
mmol/l
0.16
165
1116
406
3180
1.38
6.71
7.2
4.4
1.02
1.02
kg/l
0.01
324
2185
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
114
682
1.73
6.69
3.6
2.7
0.35
0.33
iu/ml
0.15
61
377
38
152
2.54
6.55
1.4
1.3
—
—
—
0
0
377
2929
1.38
6.52
1.8
1.7
1.50
1.64
mg/l
0.32
304
2336
501
4079
1.34
6.39
3.3
3.2
377.12
368.65
umol/l
0.95
410
3511
308
2322
1.41
6.35
1.9
1.9
—
—
—
0
0
79
431
1.88
6.30
2.5
2.3
123.23
129.19
g/l
1.11
62
341
286
2152
1.40
5.94
1.8
2.0
—
—
—
0
0
71
391
1.86
5.54
2.9
2.7
15.42
16.08
%
1.00
71
383
112
705
1.63
5.47
3.2
2.7
—
—
—
0
0
671
5782
1.28
5.41
2.4
2.3
77.94
78.02
nmol/l
0.03
581
5069
213
1549
1.44
5.33
1.8
2.3
0.21
0.20
g/l
0.96
195
1433
77
443
1.78
5.23
2.4
2.3
195.33
102.97
ug/min
0.37
38
269
531
4457
1.29
5.21
3.0
3.3
42.95
36.39
u/l
0.45
502
4199
287
2212
1.37
5.11
3.8
4.3
230.63
248.64
u/l
1.90
274
2091
75
434
1.77
5.00
1.7
1.5
—
—
—
0
0
232
1736
1.40
4.94
7.0
7.6
11.49
11.51
mmol/l
0.02
224
1657
293
2279
1.35
4.91
6.5
6.7
1.04
1.03
mmol/l
0.17
276
2128
80
480
1.70
4.72
4.0
3.4
1.61
1.62
mmol/l
0.01
80
466
242
1841
1.37
4.66
2.3
2.7
62.76
67.67
e9/l
1.56
193
1380
31
134
2.34
4.61
1.4
1.3
—
—
—
0
0
385
3174
1.28
4.20
5.0
4.4
291.93
643.53
ng/l
0.68
340
2795
379
3119
1.29
4.19
3.7
3.2
2.47
2.46
mmol/l
1.86
345
2788
68
404
1.71
4.19
4.3
3.6
7.68
7.57
mmol/l
0.12
68
391
222
1697
1.36
4.14
2.6
2.8
10.02
9.76
umol/l
0.04
197
1531
131
914
1.47
4.10
1.5
1.5
—
—
—
0
0
399
3332
1.27
3.89
1.9
1.8
436.79
16073816.96
pmol/l
1.69
312
2725
78
491
1.62
3.88
1.8
1.8
—
—
—
0
0
235
1831
1.33
3.86
6.9
8.5
120.61
121.14
g/l
0.14
228
1788
239
1869
1.33
3.83
4.2
3.8
1.29
1.94
mmol/l
2.06
205
1595
97
658
1.51
3.51
2.2
1.8
—
—
—
0
0
27
125
2.18
3.49
2.3
1.8
2.89
1.19
u/field
0.37
19
67
33
167
2.00
3.40
1.5
1.5
24.16
35.97
ng/l
0.87
33
167
123
883
1.43
3.35
1.7
1.9
1.41
2.51
ug/l
0.57
114
780
178
1360
1.35
3.34
2.6
2.5
36.28
37.30
u/l
0.08
154
1139
146
1085
1.38
3.27
7.3
10.4
16.13
15.85
%
0.58
140
1043
27
129
2.11
3.25
1.3
1.3
—
—
—
0
0
53
318
1.69
3.22
1.3
1.3
—
—
—
0
0
161
1219
1.36
3.21
3.0
3.1
56.63
59.63
ml/min/173m2
0.45
67
554
45
258
1.77
3.20
1.4
1.3
8.89
7.77
u/l
0.39
37
203
161
1221
1.36
3.18
8.2
9.4
94.30
93.81
%
0.43
161
1215
157
1188
1.36
3.15
8.2
9.4
0.53
0.63
%
3.17
157
1178
94
651
1.47
3.11
4.6
4.1
24.34
24.79
mmol/l
1.02
87
601
15
56
2.70
3.06
6.0
7.7
1.10
45.51
ug/l
—
7
40
325
2721
1.25
3.03
3.7
3.4
0.81
0.82
mmol/l
0.41
304
2566
246
2000
1.27
2.95
6.9
7.8
95.82
95.27
%
0.77
239
1929
161
1237
1.34
2.93
3.4
2.3
353.23
380.04
nmol/l
0.84
153
1141
40
228
1.77
2.93
3.1
6.4
7.37
7.46
mmol/l
0.07
34
189
160
1232
1.33
2.87
8.0
9.1
1.22
1.29
%
0.55
160
1222
66
433
1.55
2.84
3.8
3.8
2.03
1.75
index
0.17
38
239
39
223
1.77
2.83
1.9
2.0
90.19
89.22
%
0.56
39
223
589
5269
1.19
2.78
2.0
2.0
1.38
1.29
mmol/l
1.82
462
4291
199
1588
1.29
2.77
3.8
3.1
4.48
4.46
kpa
0.04
194
1541
111
813
1.39
2.74
4.5
5.7
0.85
0.85
%
0.02
106
769
99
711
1.42
2.73
2.3
2.0
—
—
—
0
0
119
884
1.38
2.70
4.3
5.5
1.71
1.57
%
0.65
114
836
58
375
1.57
2.67
1.7
1.6
31.19
24.67
u/ml
0.23
14
65
64
424
1.53
2.65
1.4
1.5
240.17
252.96
ug/g
0.16
33
277
59
384
1.56
2.64
2.3
3.5
478.75
1025.25
u/ml
0.36
53
359
356
3053
1.22
2.63
1.9
1.8
1158.44
1157.26
nmol/l
0.01
251
2313
47
290
1.64
2.62
1.9
1.7
15.26
23.14
ug/l
1.98
47
285
24
120
2.02
2.61
1.2
1.3
—
—
—
0
0
83
585
1.44
2.55
3.0
3.6
4.37
4.33
pmol/l
0.19
77
506
269
2249
1.24
2.53
1.4
1.6
3.01
2.91
g/l
0.19
161
1341
155
1213
1.31
2.51
1.7
1.6
—
—
—
0
0
11
37
2.99
2.49
2.0
1.4
—
—
—
0
0
25
130
1.94
2.46
1.3
1.3
25.19
23.41
iu/l
0.12
18
108
31
175
1.79
2.39
3.3
2.7
—
—
—
0
0
1026
9692
1.18
2.34
35.0
27.3
330.98
332.09
g/l
3.34
1019
9638
261
2194
1.23
2.34
6.7
7.6
0.31
0.89
mmol/l
1.69
212
1776
89
651
1.39
2.26
4.0
3.4
58.82
6622.54
u/ml
0.92
79
562
106
798
1.35
2.26
2.9
2.5
7.32
7.36
g/l
0.07
92
732
106
798
1.35
2.26
2.9
2.5
3.71
3.72
g/l
0.03
92
732
106
798
1.35
2.26
2.9
2.5
4.35
4.10
g/l
1.19
92
734
262
2212
1.22
2.25
6.8
7.7
5.07
5.07
kpa
0.04
252
2122
262
2213
1.22
2.24
6.7
7.7
12.25
11.73
kpa
0.89
252
2124
16
74
2.17
2.15
1.2
1.3
2445.01
173.74
ug/l
0.74
11
33
25
137
1.84
2.14
2.2
2.4
816.00
635.72
ml
—
8
88
281
2408
1.20
2.08
1.2
1.2
2.16
1.61
u/ml
0.25
64
613
5
10
5.01
2.07
2.8
1.9
0.40
0.40
u/field
—
5
10
30
176
1.72
2.06
1.5
1.5
61.69
64.76
%
0.14
16
110
7
21
3.34
1.96
1.4
1.4
—
—
—
0
0
97
738
1.34
1.96
3.1
2.5
2.93
2.98
g/l
0.15
83
673
124
978
1.29
1.94
1.6
1.8
1.68
1.53
g/l
1.04
115
838
82
609
1.37
1.94
1.3
1.4
—
—
—
0
0
40
259
1.56
1.91
1.1
1.1
—
—
—
0
0
146
1180
1.26
1.89
3.9
4.3
102.74
102.39
ng/l
0.01
118
1027
6
17
3.54
1.84
1.5
1.2
317.95
100.47
ng/l
—
6
11
65
469
1.40
1.83
2.6
2.8
1.77
1.80
mg/l
0.11
58
403
195
1637
1.22
1.79
2.6
2.8
65.68
66.12
g/l
0.36
177
1509
8
29
2.77
1.79
2.6
2.3
—
—
—
0
0
31
193
1.62
1.75
1.7
1.7
283.35
274.55
mu/l
0.04
31
182
8
30
2.68
1.72
2.8
2.3
—
—
—
0
0
84
646
1.32
1.62
3.7
3.4
1.46
2.95
ratio
1.39
50
383
48
338
1.43
1.58
1.3
1.3
—
—
—
0
0
48
338
1.43
1.58
1.3
1.3
—
—
—
0
0
7
26
2.70
1.58
1.3
1.8
—
—
—
0
0
47
330
1.44
1.57
1.6
1.6
32.86
31.40
g/l
0.34
42
297
89
695
1.30
1.55
3.2
2.6
9.57
10.74
g/l
2.10
74
625
142
1174
1.23
1.54
1.2
1.3
—
—
—
0
0
45
318
1.43
1.47
3.5
3.8
37.28
32.39
mg/l
0.27
30
219
8
167
0.48
1.47
1.3
1.8
—
—
—
0
0
90
711
1.28
1.45
3.8
3.6
66.31
84.67
mg/l
0.29
72
600
19
110
1.74
1.43
1.1
1.1
0.39
1.05
u/ml
—
10
62
90
713
1.28
1.42
3.8
3.6
65.67
61.12
mg/l
0.12
72
599
25
157
1.60
1.41
1.3
1.2
107.43
227.05
miu/ml
—
7
46
45
322
1.41
1.39
3.1
4.0
1.03
1.49
%
0.68
38
287
55
410
1.35
1.34
1.2
1.3
—
—
—
0
0
62
473
1.32
1.31
1.3
1.6
—
—
—
0
0
9
43
2.10
1.30
1.2
3.0
3.33
718.77
ug/l
—
9
43
5
18
2.78
1.28
2.2
3.3
62.72
145.46
pmol/l
—
5
18
43
311
1.39
1.27
1.1
1.3
—
—
—
0
0
33
228
1.46
1.24
1.3
1.8
1.35
4.70
iu/l
—
7
93
30
205
1.47
1.20
4.3
3.9
—
—
—
0
0
51
384
1.34
1.19
1.6
1.6
—
—
—
0
0
32
222
1.45
1.19
2.5
2.3
1580.12
205.09
u/ml
0.50
32
215
14
80
1.76
1.13
1.0
1.0
—
—
—
0
0
23
152
1.52
1.09
1.1
1.3
0.22
0.19
nmol/l
0.46
18
122
21
136
1.55
1.08
1.2
1.3
15.44
24.23
%
1.18
12
84
7
33
2.13
1.05
1.9
1.1
1.14
1.17
mmol/l
—
7
33
8
147
0.54
1.04
1.6
1.7
—
—
—
0
0
8
147
0.54
1.04
1.6
1.7
—
—
—
0
0
8
147
0.54
1.04
1.6
1.7
—
—
—
0
0
5
22
2.28
1.03
1.0
1.0
5.48
1.55
umol/l
—
5
15
14
83
1.69
1.01
1.0
1.2
—
—
—
0
0
10
175
0.57
0.98
1.3
1.8
—
—
—
0
0
11
61
1.81
0.98
1.6
2.9
4.91
4.89
kpa
0.03
11
61
11
61
1.81
0.98
1.6
2.9
9.57
10.35
kpa
0.58
11
61
48
371
1.30
0.98
1.4
1.6
—
—
—
0
0
14
84
1.67
0.98
1.2
2.3
—
—
—
0
0
0
29
0.00
0.97
0.0
1.2
—
—
—
0
0
177
1564
1.15
0.96
2.4
2.3
10.73
12.78
nmol/l
3.07
156
1366
22
318
0.69
0.96
1.5
1.7
10.15
3.92
mg/l
0.60
16
246
124
1066
1.18
0.96
4.3
3.8
23.65
24.21
mmol/l
1.41
124
1053
11
62
1.78
0.94
1.5
1.4
19.92
27.48
u/l
0.48
11
51
83
691
1.21
0.92
3.5
2.6
1.27
1.25
g/l
0.01
67
594
6
28
2.15
0.91
2.0
1.6
15.52
15.26
pmol/l
—
6
23
36
271
1.34
0.89
1.3
1.3
—
—
—
0
0
33
245
1.35
0.89
1.3
1.3
—
19.07
—
0
7
8
42
1.91
0.88
1.3
2.1
1.88
1.55
ratio
—
8
37
179
1597
1.14
0.86
3.0
2.5
6.68
7.58
ug/l
0.31
163
1428
16
104
1.54
0.84
3.0
3.5
—
—
—
0
0
34
260
1.31
0.78
4.3
4.5
11.59
11.05
pmol/l
0.08
34
260
128
1126
1.15
0.77
1.5
1.4
—
—
—
0
0
70
586
1.20
0.76
1.7
1.8
35.82
37.84
u/l
0.46
56
499
50
405
1.24
0.75
1.5
1.7
—
—
—
0
0
17
116
1.47
0.74
1.0
1.0
—
—
—
0
0
7
40
1.75
0.71
1.0
1.1
—
24.80
u/ml
—
0
5
26
195
1.34
0.69
1.2
1.1
1.00
28.77
iu/ml
—
7
34
53
440
1.21
0.65
1.4
1.4
—
—
—
0
0
169
1536
1.11
0.64
3.6
3.2
261.30
239.11
ng/l
0.26
157
1423
27
207
1.31
0.64
1.4
1.4
161.67
162.12
au/ml
—
6
60
29
225
1.29
0.63
1.4
1.6
—
—
—
0
0
46
379
1.22
0.62
5.6
7.8
105.37
105.50
mmol/l
0.07
41
339
85
741
1.16
0.61
1.3
1.4
27.42
60.92
au/ml
—
5
60
32
253
1.27
0.61
1.3
1.5
47837.47
87637.22
e6/l
0.52
19
150
18
130
1.39
0.61
1.7
2.2
8.82
7.64
mmol/l
1.01
18
130
36
289
1.25
0.61
1.4
1.3
1.16
0.82
nmol/l
1.63
26
235
0
20
0.00
0.60
0.0
4.8
—
—
—
0
0
51
427
1.20
0.59
3.3
3.3
0.92
0.82
nmol/l
0.57
45
341
62
529
1.18
0.59
1.1
1.1
103.37
136.58
u/ml
0.29
15
177
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
13
89
1.46
0.58
1.8
1.6
91.62
97.47
umol/l
0.31
13
89
6
35
1.72
0.57
2.0
1.5
112.67
83.94
nmol/24h
—
6
35
21
158
1.33
0.57
1.6
1.2
1.44
1.49
g/l
0.40
21
158
28
220
1.28
0.57
1.2
1.2
277.45
306.95
u/ml
0.12
11
118
198
1830
1.09
0.55
5.7
5.4
33.15
32.60
%
0.29
124
1166
47
394
1.20
0.55
1.6
1.5
1.35
18.99
iu/ml
0.52
11
71
18
133
1.36
0.55
1.4
1.4
—
—
—
0
0
49
414
1.19
0.53
1.6
1.8
43.94
45.84
nmol/l
0.29
49
389
20
153
1.31
0.50
1.3
1.6
—
—
—
0
0
12
84
1.43
0.49
1.4
1.4
—
—
—
0
0
28
342
0.82
0.46
1.3
1.5
—
—
—
0
0
17
129
1.32
0.45
1.1
1.5
—
—
—
0
0
14
103
1.36
0.45
1.1
1.4
1.96
1.03
promille
—
9
84
25
308
0.81
0.45
1.3
1.2
3.98
3.87
mmol/l
0.16
25
285
64
566
1.14
0.42
1.2
1.3
—
—
—
0
0
12
87
1.38
0.42
2.3
2.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
26
315
0.82
0.41
1.5
1.8
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
4739.25
—
0
12
49
430
1.14
0.37
1.6
1.6
13029.48
18347.68
e6/l
0.70
33
295
130
1206
1.09
0.37
1.4
1.7
1.64
1.65
%
0.01
102
998
137
1274
1.08
0.37
2.3
2.3
152.41
167.30
ug/g
0.24
110
1011
25
300
0.83
0.37
1.7
1.3
11.18
36.50
e6/l
0.63
17
229
20
162
1.24
0.35
1.5
1.3
7451.00
200975.23
e6/l
1.97
12
111
14
108
1.30
0.35
1.4
2.4
—
—
—
0
0
6
43
1.40
0.35
1.0
1.4
70.00
131.83
nmol/l
—
6
29
19
154
1.24
0.34
1.3
1.2
1.18
1.55
nmol/l
1.20
19
140
6
88
0.68
0.33
2.0
1.9
—
—
—
0
0
26
306
0.85
0.32
1.8
1.3
592.80
665.61
e6/l
0.04
20
244
18
146
1.24
0.32
3.8
3.8
14.33
11.06
index
0.35
12
88
11
83
1.33
0.32
1.1
1.2
—
—
—
0
0
12
92
1.31
0.32
3.0
2.4
—
—
—
0
0
14
110
1.28
0.31
1.1
1.5
—
—
—
0
0
15
120
1.25
0.30
1.1
1.4
—
51.11
—
0
9
15
185
0.81
0.30
1.2
1.5
—
—
—
0
0
7
56
1.25
0.29
1.0
1.2
5.74
20.59
umol/l
—
7
36
33
288
1.15
0.29
1.4
1.5
1391.64
4630.19
e6/l
0.55
25
203
8
107
0.75
0.29
1.0
1.0
292.25
283.25
mg/l
—
8
96
13
103
1.26
0.28
1.2
1.1
—
—
—
0
0
126
1185
1.07
0.28
6.7
7.1
24.33
24.34
mmol/l
0.01
119
1131
8
65
1.23
0.27
1.9
1.5
—
—
—
0
0
9
72
1.25
0.25
2.0
1.2
—
—
—
0
0
29
330
0.88
0.25
5.0
6.0
2374.67
741.40
iu/ml
—
6
48
14
114
1.23
0.25
1.1
1.5
—
—
—
0
0
18
152
1.19
0.23
2.1
1.6
—
—
—
0
0
11
88
1.25
0.22
1.1
1.1
—
—
—
0
0
11
88
1.25
0.22
1.1
1.1
—
—
—
0
0
26
295
0.88
0.22
1.3
1.5
—
—
—
0
0
13
107
1.22
0.21
1.3
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
4.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
42
460
0.91
0.21
1.5
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
13
108
1.21
0.20
1.3
1.4
—
—
—
0
0
21
184
1.14
0.19
1.3
1.4
—
—
—
0
0
6
53
1.13
0.18
1.5
2.3
0.58
0.61
mmol/l
—
6
53
17
147
1.16
0.18
1.4
1.5
38.40
23.09
u/ml
—
5
22
7
60
1.17
0.17
5.6
4.5
13.41
13.42
%
—
7
60
86
815
1.06
0.17
2.6
2.6
16.18
18.68
au/ml
—
5
58
7
63
1.11
0.17
1.3
1.5
6.03
9.35
u/l
—
7
52
21
186
1.13
0.17
1.3
1.4
—
—
—
0
0
17
148
1.15
0.17
1.5
1.8
3.68
5.06
mg/l
1.51
17
142
24
215
1.12
0.16
3.3
4.1
64.29
59.37
%
0.42
18
185
11
92
1.20
0.16
5.4
3.4
0.55
0.89
%
0.48
11
92
46
428
1.08
0.16
1.1
1.0
—
—
—
0
0
21
187
1.12
0.16
1.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
39
361
1.08
0.15
1.4
1.8
11.80
12.52
mg/l
0.17
32
326
7
87
0.80
0.14
1.7
1.9
—
—
—
0
0
7
87
0.80
0.14
1.7
1.9
—
—
—
0
0
7
87
0.80
0.14
1.7
1.9
—
—
—
0
0
7
87
0.80
0.14
1.7
1.9
—
—
—
0
0
7
88
0.79
0.14
4.6
2.0
0.59
0.68
e9/l
—
7
81
13
112
1.16
0.14
2.2
2.3
19.00
37.99
iu/ml
—
5
20
46
491
0.93
0.14
3.2
1.7
9.63
7.53
iu/ml
0.23
13
122
63
665
0.95
0.14
2.2
2.1
3.33
3.45
ratio
0.42
51
552
10
84
1.19
0.14
1.1
1.2
—
—
—
0
0
43
459
0.94
0.13
1.5
1.6
—
—
—
0
0
12
104
1.16
0.12
1.2
1.2
—
—
—
0
0
14
158
0.89
0.12
1.4
1.2
2.50
3.61
u/ml
—
8
56
174
1783
0.97
0.11
8.0
8.3
—
—
—
0
0
42
445
0.94
0.11
2.0
1.9
3.29
3.31
mmol/l
0.04
29
337
11
96
1.15
0.10
1.1
1.1
—
—
—
0
0
5
44
1.14
0.10
1.2
1.2
—
—
—
0
0
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
32
339
0.94
0.08
1.2
1.2
7.20
3.58
u/ml
—
5
29
204
2004
1.02
0.08
1.3
1.3
38.96
38.29
iu/ml
0.02
69
599
6
57
1.05
0.08
1.2
1.4
34.33
28.11
umol/l
—
6
50
192
1886
1.02
0.08
1.2
1.3
18.42
11.80
u/ml
0.50
61
665
8
74
1.08
0.07
1.0
1.6
42.84
39.24
g/l
—
8
74
8
75
1.07
0.07
1.5
1.4
—
—
—
0
0
8
75
1.07
0.07
1.5
1.4
—
—
—
0
0
13
143
0.91
0.07
1.2
1.1
—
—
—
0
0
8
78
1.03
0.07
1.0
1.1
—
—
—
0
0
34
357
0.95
0.07
1.2
1.2
—
23.29
—
0
14
7
82
0.85
0.07
1.4
1.3
115.53
162.42
pmol/l
—
7
82
23
216
1.07
0.07
2.0
2.3
19.33
17.92
mg/l
—
6
79
16
173
0.92
0.06
2.0
2.5
1343.62
916.90
mg
0.27
16
173
8
95
0.84
0.06
1.0
1.3
91.75
92.76
pmol/l
—
8
95
45
433
1.04
0.06
1.1
1.2
—
—
—
0
0
9
101
0.89
0.06
1.0
1.1
—
—
—
0
0
16
148
1.08
0.06
1.9
1.2
—
—
—
0
0
60
582
1.03
0.06
3.5
2.5
0.21
0.03
g/l
0.61
55
524
32
335
0.95
0.06
1.3
1.5
—
—
—
0
0
58
564
1.03
0.05
3.5
2.5
0.00
0.00
g/l
-0.00
51
498
18
191
0.94
0.04
1.2
1.1
—
6.67
—
0
6
10
91
1.10
0.04
1.0
2.5
—
—
—
0
0
13
139
0.93
0.03
1.5
1.7
—
1373.33
—
0
6
17
179
0.95
0.03
1.3
1.4
—
—
—
0
0
48
491
0.98
0.03
1.5
1.6
0.22
0.35
mg/l
1.55
25
226
21
201
1.05
0.03
1.0
1.1
1.58
1.58
g/l
0.01
21
184
33
340
0.97
0.03
1.2
1.2
2.67
3.66
u/ml
—
6
44
36
350
1.03
0.03
1.1
1.2
—
—
—
0
0
17
178
0.95
0.02
1.3
1.4
—
—
—
0
0
17
178
0.95
0.02
1.3
1.4
—
—
—
0
0
50
509
0.98
0.02
4.8
4.0
4.00
4.00
mmol/l
0.04
50
501
38
388
0.98
0.01
1.4
1.5
—
—
—
0
0
10
106
0.94
0.01
1.0
1.0
—
—
—
0
0
35
356
0.98
0.00
1.6
1.6
—
—
—
0
0
35
346
1.01
0.00
1.1
1.2
—
—
—
0
0
11
108
1.02
0.00
1.2
1.1
2.72
2.26
mmol/l
0.31
11
100
23
228
1.01
0.00
1.3
1.3
—
—
—
0
0
18
181
0.99
0.00
1.1
1.0
—
—
—
0
0
10
103
0.97
0.00
1.0
1.0
5.52
2.64
eliau/ml
—
5
25
24
237
1.01
0.00
1.5
1.6
—
—
—
0
0
5
50
1.00
0.00
1.2
1.0
1287.00
1446.52
miu/ml
—
5
50
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
49.52
—
0
6
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
383.40
—
0
5
16
160
1.00
-0.00
1.3
1.2
9.89
7.47
u/ml
—
9
78
0
6
0.00
-0.00
0.0
1.5
—
2.33
—
0
6
9
90
1.00
-0.00
1.1
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.04
—
0
5
7
79
0.89
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
79
0.89
-0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
9
90
1.00
-0.00
1.1
1.3
—
—
—
0
0
5
53
0.94
-0.00
1.2
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OTHER_NOS – Carcinoma in situ of other and unspecified sites
GWS hits: 3
This endpoint is excluded from FinRegistry analyses (omitted endpoint).